US EditionFunding cuts threaten ‘success story’ of efforts to combat HIV/Aids
- In January, a U.S. Foreign aid funding freeze, enacted by the Trump administration, impacted USAID and Pepfar, leading to program halts and staffing reductions.
- The funding cuts, including the halt of approximately $440 million for South Africa's ARV treatment program provided through Pepfar, were described by President Cyril Ramaphosa as a “wake-up call” for South Africa to become more self-reliant.
- The funding freeze led to the closure of a men's health clinic in Johannesburg, impacting comprehensive HIV treatment and services for the LGBTQI+ community, resulting in over 70 employees losing their jobs and concerns about access to services for those in need.
- Dr. Abuogi, who worked on PEPFAR programs, witnessed clinics in Kenya, normally serving 200 patients daily, become deserted and staff confused after services were abruptly stopped without a plan, highlighting the cruelty and chaos of the situation.
- A modeling study published in The Lancet HIV on March 26 projects that these funding cuts by top donors like the U.S. Could lead to an estimated 10.8 million more HIV cases and 2.9 million more HIV-related deaths by 2030, threatening global HIV goals and potentially undoing progress achieved since 2000.
108 Articles
108 Articles
What Happens If a Highly Effective HIV-Prevention Drug Is No Longer Free?
Black queer activist Preston Mitchum has been on PrEP — pre-exposure prophylaxis, a medication used to reduce the risk of getting HIV — since around 2014, just two years after its approval by the U.S. Food and Drug Administration. The Washington, D.C., resident remembers the barriers he and many others faced when trying to secure PrEP before 2021, when almost all private insurers had to start making the drug available at no cost to patients unde…
Major HIV drug maker to cut nearly 150 Bay Area jobs
(KRON) -- On the same day the Trump Administration unceremoniously shut down the U.S. Department of Health and Human Services Regional Office in San Francisco, a major HIV drug maker announced it would be cutting nearly 150 Bay Area jobs. Gilead Sciences, which is headquartered in Foster City on the Peninsula, will be laying off 149 people, according to a filing with the Employment Development Department. The cuts at Gilead, which in addition to…
As US Cuts HIV Assistance, South Africa Turns to Miners, Insurer
Weeks after the administration of US President Donald Trump gutted the country’s aid programs, canceling billions of dollars of funding used to fight HIV in Africa, mining companies and South Africa’s biggest health insurer are offering to help fill the gap.
San Diego doctors say Trump cuts to medical research funding could impact people's health
For weeks, we’ve been hearing about possible funding cuts to the National Institutes of Health and how it could impact medical research. Now, the head of one research organization in San Diego was notified of cuts to be made. For decades, medical researchers at UC San Diego like Dr. Davey Smith have been at the forefront of medical advancements in HIV treatment, such as helping to develop the blockbuster drug Truvada. “We’ve been doing HIV resea…
Coverage Details
Bias Distribution
- 44% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
